Skip to main content
Independent Editorial Analysis
11 historical events · Editorial analysis

Kimberly-Clark Company Profile: Revenue, Business Model & Strategy

Research depth: 11 milestones · 10 FAQs

Kimberly-Clark is a Dallas-based consumer staples company that makes Huggies, Kleenex, Scott, Cottonelle, Kotex and Depend. It reported $16.447 billion in FY2025 net sales from continuing operations, is led by Chairman and CEO Mike Hsu, and is acquiring Kenvue in a deal valued at about $48.7 billion.

How Kimberly-Clark makes money: Kimberly-Clark makes money by manufacturing and selling branded disposable hygiene and tissue products through retailers, e-commerce and distributors.

Annual Revenue (FY2025)$16.4B
Employees36,000
CEOMike Hsu
Founded1872
IndustryConsumer Packaged Goods and Disposable Hygiene Products
By Swet ParvadiyaLast reviewed:

Kimberly-Clark Corporation key figures

Kimberly-Clark Corporation had revenue of $16.4B for fiscal year 2025, down 2.1% from FY2024. Net income was $2B, a net margin of 12.3%.

Source: KIMBERLY-CLARK CORPORATION annual report (Form 10-K, SEC EDGAR, filed 2026-02-12) · Last reviewed October 2026

Revenue growth, FY2016 to FY2025
-1.1% a year
Compound annual rate, $18.2B to $16.4B
Peak revenue year
FY2022
$20.2B; the latest reported year is 18.5% below the peak
Revenue per employee
$456,861
FY2025 revenue divided by 36,000 employees; headcount may use another date
Current chief executive
Mike Hsu
In the role since 2019 (7 years)
Documented transactions
4
Between 1995 and 2026
Founded
1872
154 years ago
Where was Kimberly-Clark founded?
Kimberly-Clark was founded in Wisconsin, United States in 1872. wikidata.org
When did Kimberly-Clark start?
Kimberly-Clark was founded in 1872.
Who founded Kimberly-Clark?
Kimberly-Clark was founded by John A. Kimberly, Frank C. Shattuck, Havilah Babcock and Charles B. Clark.
How old is Kimberly-Clark?
Kimberly-Clark is 154 years old as of 2026.
In-Depth Analysis
450 words · 3 min read

Kimberly-Clark possesses a historic, industrial American lineage. It was founded in 1872 in Neenah, Wisconsin, by John A. Kimberly, Havilah Babcock, Charles B. Clark, and Franklyn C. Shattuck. For its first half-century, the company operated as a successful, traditional manufacturer of newsprint and vast quantities of bulk paper. The distinct, world-altering transformation of the significant company occurred during World War I. The company's effective scientists developed "cellucotton", an advanced, absorbent cotton substitute originally designed entirely for critical surgical bandages for the military.

The Invention of Kotex and Kleenex

Following the war, the company desperately needed a lucrative commercial use for its strong cellucotton manufacturing capacity. In an aggressive, marketing breakthrough, they rebranded the absorbent material as Kotex (the first successful disposable feminine hygiene product) in 1920. In 1924, they executed an even more well-known launch: Kleenex. Originally marketed as a cold-cream remover for Hollywood makeup, consumers quickly began using it as a disposable handkerchief. Kleenex became an, major cultural phenomenon, permanently establishing Kimberly-Clark as a lucrative pioneer of the disposable consumer economy.

The Darwin Smith Turnaround (The Good to Great Era)

Despite its major early success, by the 1970s, Kimberly-Clark was stagnant, burdened by its capital-intensive, unprofitable "coated paper" mill division. In 1971, Darwin E. Smith, the unassuming internal legal counsel, became CEO. He executed one of the most famous, aggressive corporate turnarounds in American history (featured in Jim Collins' famous business book, *Good to Great*). Smith sold off the entire, legacy paper mill business. He redirected the prominent capital entirely into the lucrative, high-margin consumer brands, essentially declaring total war on the market leader, Procter & Gamble.

The Huggies Diaper War (Battling P&G)

The lucrative financial reality of modern Kimberly-Clark was forged in the severe, "diaper wars" against Procter & Gamble (Pampers). In 1978, Kimberly-Clark launched Huggies, an engineered, premium disposable diaper. This sparked a prominent, multi-decade battle of incredible R&D innovation (adding elastic leg gathers, complex super-absorbent polymers). The intense competition forced Kimberly-Clark to become agile and aggressive. Huggies eventually captured strong market share, becoming the true, lucrative multi-billion-dollar cash cow of the significant empire.

The Threat of Private Label and Commodity Costs

Today, Kimberly-Clark is a, entrenched global leviathan, but it faces two existential, permanent threats. First, the substantial, volatile cost of global commodities (raw wood pulp, resin). When these costs violently spike, Kimberly-Clark's significant profit margins are heavily pressured. Second, the aggressive rise of high-quality "private label" (store brand) products from retailers like Costco and Walmart. The permanent, challenge for Kimberly-Clark is continuously spending billions of dollars on aggressive marketing and R&D to convince squeezed global consumers that the premium Kleenex or Huggies logo is actually worth paying a prominent price premium over the generic alternative.

Kimberly-Clark Corporation Key Facts

CompanyKimberly-Clark Corporation
Annual revenue change-2.1% (FY2024–FY2025)
Financials$16.4B (FY2025, last reviewed October 2026)
Market Cap$33.0B
FY2025 net income$2.0B
Last reviewedBy Swet Parvadiya, Founder & Editor - October 2026
Founded1872
Founder(s)John A. Kimberly, Havilah Babcock, Charles B. Clark, Frank C. Shattuck
CEOMike Hsu
HeadquartersDallas, Texas
IndustryConsumer Packaged Goods and Disposable Hygiene Products
Employees36,000+

Kimberly-Clark Company Profile: Revenue, Business Model & Strategy

"Kimberly-Clark turned a World War I bandage material into Kotex and Kleenex, and a century later it sells Huggies, Kleenex and Depend in about 175 countries. FY2025 net sales from continuing operations were $16.447 billion with about 36,000 employees. Its pending $48.7 billion acquisition of Kenvue would roughly double its revenue base and move it into consumer health."

Why Kimberly-Clark Corporation Wins

Kimberly-Clark wins because it has built a proprietary material science and nonwoven manufacturing infrastructure combined with a global brand portfolio that includes genericized trademarks like Kleenex and Andrex, creating a level of operational scale, consumer trust, and retail negotiating power that no competitor can replicate. The material science advantage operates on a scale, with the company employing thousands of engineers and chemists who maintain deep, proprietary expertise in absorbent core geometry, nonwoven fabric extrusion, and tissue creping technologies, allowing Kimberly-Clark to manufacture products that offer superior softness, absorbency, and strength at a lower cost per unit than competitors. This direct access to the material science source allows Kimberly-Clark to control the cost, quality, and timing of its inventory with a level of precision that is impossible for competitors who rely on external vendors, enabling the company to maintain its premium pricing architecture and its high-margin product assortment even in an inflationary environment.

Kimberly-Clark Corporation operates in a competitive market alongside The Procter & Gamble Company, Colgate-Palmolive Company, Johnson & Johnson, Unilever PLC. Analysts frequently compare Kimberly-Clark Corporation and The Procter & Gamble Company due to their overlapping products, target markets, and strategic positioning.

Kimberly-Clark is a Dallas-based consumer staples company that makes Huggies, Kleenex, Scott, Cottonelle, Kotex and Depend. It reported $16.447 billion in FY2025 net sales from continuing operations, is led by Chairman and CEO Mike Hsu, and is acquiring Kenvue in a deal valued at about $48.7 billion.

Revenue

$16.4B

Founded

1872

Employees

36K+

Market Cap

$33.0B

Key Facts

  • Founded: Kimberly-Clark Corporation was established in 1872 and is headquartered in Dallas, Texas.
  • Revenue: Kimberly-Clark Corporation had $16.4B in annual revenue (FY2025).
  • Valuation: Market capitalization of approximately $33.0B.
  • Scale: Kimberly-Clark Corporation employs 36,000 people globally.
  • Business Model: Kimberly-Clark makes money by manufacturing and selling branded disposable hygiene and tissue products.
  • Competitive Edge: Kimberly-Clark's advantages are category-defining brands (Kleenex is used as a generic word for tissue), large-scale.

How Kimberly-Clark Makes Money

Capital Allocation & Scaling Mechanics

Kimberly-Clark makes money by manufacturing and selling branded disposable hygiene and tissue products through retailers, e-commerce and distributors. Since 2024 it reports two segments: North America (consumer brands such as Huggies, Kleenex, Cottonelle, Scott, Depend and Poise, plus the North American professional business) and International Personal Care (diapers, feminine care and adult care outside North America). The International Family Care and Professional tissue business is reported as discontinued operations after being contributed to the Arbex joint venture with Suzano. Profit depends on pricing power, mix toward premium products, and productivity savings that offset pulp, resin and energy costs.

What Is Kimberly-Clark Corporation's Growth Strategy?

Under its Powering Care strategy, Kimberly-Clark focuses on premium innovation (such as Huggies Skin Essentials and Depend upgrades), productivity savings, exiting low-margin businesses like US private-label diapers, and moving its international tissue business into the Arbex joint venture. It is also building an alternative natural fibers pilot plant in the US Southwest using the drought-tolerant hesperaloe plant. The Kenvue acquisition is the largest bet, adding consumer health brands to its hygiene portfolio.

How Much Revenue Does Kimberly-Clark Generate?

FY2025 net sales from continuing operations were $16.447 billion, down 2.1% from $16.805 billion in 2024, largely reflecting exits such as US private-label diapers and currency. Gross profit was $5.923 billion, operating profit $2.351 billion and net income attributable to Kimberly-Clark $2.021 billion. In Q2 2026 net sales were $4.19 billion (up 0.6%), adjusted gross margin rose 190 basis points to 38.8%, and adjusted EPS attributable to the company was $2.12, while reported net income fell to $345 million from $509 million on deal and restructuring costs. Market value was about $33 billion in late September 2026. Kimberly-Clark Corporation is a colossal American multinational personal care corporation, commanding a market valuation typically over $45 billion.

Financial MetricEstimated Value (2026)
Market Capitalization$33.0B
Employee Count36,000 +
Latest Annual Revenue$16.4B (FY2025)

Historical Revenue Chart

Kimberly-Clark Corporation Annual Revenue History

All figures in USD.

Fiscal YearRevenue FigureYoY Change
FY2016$18.2BN/A
FY2017$18.3B+0.8%
FY2018$18.5B+0.8%
FY2019$18.4B-0.2%
FY2020$19.1B+3.7%
FY2021$19.4B+1.6%
FY2022$20.2B+3.8%
FY2023$17.1B-15.0%
FY2024$16.8B-2.0%
FY2025$16.4B-2.1%

The source for each year is listed on the Kimberly-Clark Corporation financials page.

Core Strength

Category-defining brands, with Kleenex used as a generic word for tissue, backed by large-scale nonwoven and absorbent manufacturing that is expensive to replicate and long retailer relationships.

Key Weakness

Slow volume growth in mature diaper and tissue markets, private-label competition, and pulp, resin and tariff cost swings.

Who Are Kimberly-Clark Corporation's Main Competitors?

Kimberly-Clark's main rival is Procter & Gamble, whose Pampers competes with Huggies in diapers and whose Charmin and Bounty compete with Cottonelle, Scott and Viva in tissue and towels. Essity (Libero, TENA, Tork, Bodyform) competes in Europe, Latin America and professional hygiene, while Georgia-Pacific (Koch Industries) is a major North American tissue and away-from-home supplier. Unicharm is a strong diaper and feminine care competitor in Asia, and retailer private labels pressure prices across every category. In adult incontinence, Depend and Poise compete with Essity's TENA and store brands. The Kenvue deal would extend the competitive set into consumer health, against Haleon, P&G Health and Bayer Consumer Health.

Top CompetitorsHead-to-Head Analysis
Colgate-Palmolive CompanyCompare vs Colgate-Palmolive Company→

What Is Kimberly-Clark Corporation's Full Historical Timeline?

Historical Timeline & Strategic Pivots

Key Milestones

1872 -

Shattuck found the company in Neenah, Wisconsin, establishing the foundation for the paper manufacturing operation that would eventually become a global leader in disposable hygiene products.

1914 -

A team of company researchers, including Frank A. Shattuck, invents Cellucotton, an absorbent wood pulp fiber that was five times more absorbent than traditional surgical cotton, transforming the hygiene industry.

1920 -

Kimberly-Clark adapts Cellucotton to create Kotex sanitary napkins, creating an entirely new product category that generated billions in lifetime revenue and established the company as a pioneer in disposable feminine care.

1924 -

Kimberly-Clark introduces Kleenex facial tissues, initially marketed as a cold cream remover, which subsequently evolved into the dominant facial tissue brand globally, achieving genericized trademark status in many regions.

1985 -

Kimberly-Clark moves its global headquarters from Neenah, Wisconsin, to Irving, Texas, a strategic move designed to optimize its global supply chain, access a broader talent pool, and reduce operational costs.

1995 -

Under the leadership of then-CEO Darwin Smith, Kimberly-Clark acquires the Scott Paper company in a $9.4 billion transaction, instantly doubling its tissue capacity and adding well-known brands like Scott and Cottonelle to its portfolio.

2014 -

Kimberly-Clark spun off its healthcare business as Halyard Health in October 2014.

2019 -

Mike Hsu became CEO of Kimberly-Clark in 2019. Shifted Kimberly-Clark toward premium innovation and productivity savings and is repositioning it as a broader health and wellness company.

2024 -

Kimberly-Clark generates $19.5 billion in net sales for the fiscal year ended December 31, 2024, reflecting a strong stabilization of revenue following the post-pandemic normalization of consumer purchasing patterns and the successful implementation of aggressive pricing actions.

2025 -

Kimberly-Clark reported $16.447 billion in FY2025 net sales from continuing operations, $2.351 billion in operating profit, $2.021 billion in net income attributable to the company, and about 36,000 employees while reshaping the portfolio through the IFP transaction and pending Kenvue acquisition.

Risks & Weaknesses

Analytical Assessment

Primary Risk Factor

The single biggest risk facing Kimberly-Clark Corporation is the extreme volatility and unpredictability of global raw material costs, specifically the prices of fluff pulp, superabsorbent polymers, and polyethylene resins, which serve as the foundational inputs for the company's entire product portfolio. Unlike traditional consumer goods companies that can easily pass cost increases onto consumers through simple price hikes, Kimberly-Clark operates in an elastic retail environment where aggressive price increases on essential hygiene products can trigger immediate consumer trade-down to private-label alternatives, meaning that any mismatch between raw material cost inflation and retail pricing power directly compresses the company's gross margin. If global pulp prices experience a sudden spike due to supply chain disruptions, mill closures in Scandinavia or South America, or energy cost increases in Europe, the company is forced to either absorb the higher costs and accept margin compression or implement aggressive retail price increases that risk losing valuable shelf space and consumer market share to competitors.

Risk assessment based on public filings, SWOT analysis, and verified industry data. Not financial advice.

How Did Kimberly-Clark Start and Grow?

Established

1872

Fiscal Revenue (FY2025)

$16.4B

Workforce

36K+

HQ Location

Dallas, Texas

Key Turning Point

: The Strategic Shift That Created a Behemoth

Kimberly-Clark pivoted from a traditional paper manufacturer to a pioneer in disposable hygiene products following the invention of Cellucotton, an absorbent wood pulp fiber that was five times more absorbent than traditional surgical cotton.

Explore Kimberly-Clark In Depth

Detailed research across every dimension of Kimberly-Clark — history, financials, leadership, and strategy.

Related Company Comparisons

CorpDigest Research Desk

Research Profile

Our analysts compile business strategy profiles from public financial filings, press releases, and analyst reports. Each profile is reviewed for accuracy before publication by our editorial desk and updated on a rolling basis.

Frequently Asked Questions About Kimberly-Clark

What does Kimberly-Clark do?

Kimberly-Clark makes diapers, tissue, feminine care and adult incontinence products under brands such as Huggies, Kleenex, Scott, Cottonelle, Kotex, Depend and Poise, sold in about 175 countries.

How does Kimberly-Clark make money?

It sells branded personal care and tissue products to retailers, e-commerce platforms and distributors. FY2025 net sales from continuing operations were $16.447 billion, reported in two segments: North America and International Personal Care.

Who is the CEO of Kimberly-Clark?

Mike Hsu is Chairman and CEO. He became CEO in January 2019 and chairman in 2020.

Who owns Kimberly-Clark?

Kimberly-Clark is a public company traded on Nasdaq under KMB. Its largest shareholders are institutional investors led by Vanguard, BlackRock and State Street.

Where is Kimberly-Clark headquartered?

Kimberly-Clark lists its headquarters in Dallas, Texas. Its shares trade on Nasdaq under the ticker KMB.

Is Kimberly-Clark buying Kenvue?

Yes. Kimberly-Clark agreed in November 2025 to acquire Kenvue, maker of Tylenol, Band-Aid and Listerine, in a cash-and-stock deal valued at about $48.7 billion. Shareholders approved it in January 2026 and the company expects to close by the end of 2026, pending regulatory approvals.

Who are Kimberly-Clark's main competitors?

Procter & Gamble (Pampers, Charmin, Bounty), Essity (TENA, Libero, Tork), Unicharm, Georgia-Pacific and retailer private labels. After the Kenvue deal it would also compete with Haleon and other consumer health companies.

What happened to Kimberly-Clark's international tissue business?

Its International Family Care and Professional business was combined into Arbex, a joint venture with Suzano launched in 2026, and is reported as discontinued operations.

Is Kimberly-Clark a Dividend King?

Yes. Kimberly-Clark has raised its dividend for more than 50 consecutive years, though analysts have questioned payout coverage given Kenvue deal debt.

Who makes Kleenex?

Kleenex is a registered trademark of the Kimberly-Clark Corporation, which first introduced the facial tissue in 1924.

Analysis: How Kimberly-Clark Corporation Makes Money

Deep dive into the Kimberly-Clark Corporation business model, revenue streams, and strategic moats in 2026.

Financial data on this page is sourced from SEC EDGAR filings, official earnings releases, and verified press statements. Revenue figures are reviewed and updated periodically. Read our full data methodology ->

Explore More Brand Histories

This corporate intelligence report on Kimberly-Clark Corporation compiles data from verified filings. Explore more detailed brand histories and company histories in the global Consumer Packaged Goods and Disposable Hygiene Products marketplace.

Compare Kimberly-Clark Corporation With

Editorial Methodology

Company Research

We use company filings, annual reports, company statements and press reports, with primary sources preferred where available. Each financial row shows its recorded source. Full-year figures are separated from annualized run-rates, partial periods and forecasts; unaudited figures carry a label. Source detail varies by company, so check the linked material when the reporting basis matters.

1. Primary Sources

Public companies may provide filings and annual reports. Private-company figures may come from statements or press coverage. A missing figure stays missing, and a source link should identify where its number came from.

2. Expert Curation

We organize company records and review claims for strategic context, source quality and clarity. Pages show a review date where one is recorded.

3. Multi-Pass Audit

Technical checks flag inconsistent figures and missing links. Editorial review of the underlying source remains necessary for claims those checks cannot verify.

Swet Parvadiya
SEC filings & public records methodology
Sourced from public financial records

Explore Related Pages for Kimberly-Clark Corporation

Sources & References

Related Competitor Intelligence

Compare market positioning with top industry peers

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.